ABHD17AP7

Across TCGA pan-cancer cohorts, ABHD17AP7 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated ABHD17AP7 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher ABHD17AP7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ABHD17AP7 expression acts as an unfavorable survival marker.

LUSC, LIHC, and LGG are the cancer types where ABHD17AP7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	All	0.047	0.776	<.001	108	view →
LIHC	DFS	Tertile	All	0.063	0.555	<.001	99	view →
LGG	OS	Tertile	All	0.101	0.909	<.001	18	view →
THCA	DFS	Tertile	All	0.205	0.814	.035	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

ABHD17AP7–LUSC (OS)

Open the LUSC breakdown →